Dr. Robert A. Feldman, MD

Dr. Feldman practices at South Miami Surgery Center LLC in South Miami, Florida.

Dr. Feldman's NPI, 1053394205, was assigned on November 22, 2005. Dr. Feldman graduated from University of Miami, Miller School of Medicine in 1984. Dr. Feldman holds Florida license ME0047565.

Dr. Feldman's primary practice is South Miami Surgery Center LLC, at 6141 Sunset Dr, South Miami, FL 33143 in Miami-Dade County. The practice phone is (305) 596-7494.

Dr. Feldman's primary practice is South Miami Surgery Center LLC in South Miami, Florida. Dr. Feldman is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Florida Woman Care. Dmand AI also links Dr. Feldman to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 5 sites in all. Vendor and product names are available with a free account.

Obstetrics is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207VX0000X. Dr. Feldman is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dr. Feldman is licensed in Florida.

Dmand AI lists menopause, ovarian cyst, pelvic prolapse, UTI and vaginal infection among the conditions Dr. Feldman treats.

CMS data shows 445 Medicare services from Dr. Feldman across 9 procedure codes in 2024, for 154 Medicare patients. Medicare paid $20,246 for them. Every service was in an office.

CMS counts 154 Medicare patients who saw Dr. Feldman in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high cholesterol, and 49% have arthritis. Their average risk score is 0.75, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 55, with 98% women.

In 2024, Dr. Feldman wrote 366 Medicare Part D claims for 108 patients. 85% of them were for generic drugs. CMS names the drug for 209 of them, across 8 drugs with 11 or more claims each, at $12,173 in total drug cost. In 2023, CMS named 159 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Feldman for performance year 2024, reported as part of a group. Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Feldman, published from 2015 to 2021. The most frequent topics are Hydrocarbons, Fluorinated and Pyrimidines. Dr. Feldman's most frequent co-authors are Ronald T. Ackerman, MD, David Fitzgerald Archer, MD and Robert L. Feldman, MD.

Dmand AI links Dr. Feldman to 1 clinical trial. Conditions studied include Meningococcal Infections and Meningitis. Open Payments lists research payments to Dr. Feldman that name 1 trial.

CMS Open Payments shows 231 general payments to Dr. Feldman from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Duchesnay USA Incorporated paid the most, $21,182. It also lists 2 research payments totaling $8,282 in 2016, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Feldman.

Dr. Feldman graduated from University of Miami, Miller School of Medicine in 1984. Dr. Feldman is a member of American College of Obstetricians and Gynecologists.

Dr. Feldman is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.